The Journal of Experimental Medicine · 2003 · 909 citations · 57 references
Life SciencesImmunologyNeurologyInflammationNeuroimmunologySepsisAcute Ischemic StrokeCellular Immunity In InfectionImmune Responses To InfectionNeuroprotectionSepsis PathophysiologyStrokeAntibacterial Host ResponseInflammatory Cytokine ProductionRodent Cerebral IschemiaSympathetic ActivationSympathetic Nervous System ModulationSympathetic Nervous System PhysiologyT Cell Cytokine ProductionT Helper Cell Cytokines
Infections are a leading cause of death in stroke patients. The study tests whether stroke‑induced immunodeficiency increases susceptibility to bacterial infections. The authors used a mouse model of focal cerebral ischemia to examine this hypothesis. Three days after ischemia, all mice developed septicemia and pneumonia, accompanied by extensive lymphocyte apoptosis and a shift from Th1 to Th2 cytokine production, and adoptive transfer of T and NK cells or IFN‑γ administration markedly reduced bacterial burden, while sympathetic blockade prevented the IFN‑γ defect and lowered mortality, indicating that catecholamine‑mediated lymphocyte dysfunction drives post‑stroke bacterial infections.
Infections are a leading cause of death in stroke patients. In a mouse model of focal cerebral ischemia, we tested the hypothesis that a stroke-induced immunodeficiency increases the susceptibility to bacterial infections. 3 d after ischemia, all animals developed spontaneous septicemia and pneumonia. Stroke induced an extensive apoptotic loss of lymphocytes and a shift from T helper cell (Th)1 to Th2 cytokine production. Adoptive transfer of T and natural killer cells from wild-type mice, but not from interferon (IFN)-γ–deficient mice, or administration of IFN-γ at day 1 after stroke greatly decreased the bacterial burden. Importantly, the defective IFN-γ response and the occurrence of bacterial infections were prevented by blocking the sympathetic nervous system but not the hypothalamo-pituitary-adrenal axis. Furthermore, administration of the β-adrenoreceptor blocker propranolol drastically reduced mortality after stroke. These data suggest that a catecholamine-mediated defect in early lymphocyte activation is the key factor in the impaired antibacterial immune response after stroke.
57
Medical Complications After Stroke
Peter Langhorne, David J. Stott, Laura Robertson et al. · Stroke · 2000 · 1.2K citations
Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
Wolf‐Dietrich Döcke, Felix Randow, Uta Syrbe et al. · Nature Medicine · 1997 · 1.2K citations
The effect of pneumonia on mortality among patients hospitalized for acute stroke
Irene Katzan, Randall D. Cebul, S. H. Husak et al. · Neurology · 2003 · 558 citations
Complications After Acute Stroke
Richard Davenport, Martin Dennis, Ian Wellwood et al. · Stroke · 1996 · 549 citations
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte
Richard S. Hotchkiss, K. Chang, Paul E. Swanson et al. · Nature Immunology · 2000 · 527 citations